| 000 | 01466 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517194209.0 | ||
| 264 | 0 | _c20190130 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1532-8406 | ||
| 024 | 7 |
_a10.1016/j.arth.2017.11.031 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYeganeh, Mehrnoush H | |
| 245 | 0 | 0 |
_aRheumatoid Arthritis, Disease Modifying Agents, and Periprosthetic Joint Infection: What Does a Joint Surgeon Need to Know? _h[electronic resource] |
| 260 |
_bThe Journal of arthroplasty _c04 2018 |
||
| 300 |
_a1258-1264 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadverse effects |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aArthroplasty _xmethods |
| 650 | 0 | 4 |
_aArthroplasty, Replacement _xadverse effects |
| 650 | 0 | 4 | _aElective Surgical Procedures |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOsteoarthritis _xsurgery |
| 650 | 0 | 4 | _aPostoperative Period |
| 650 | 0 | 4 |
_aProsthesis-Related Infections _xdrug therapy |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSurgeons |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aKheir, Michael M | |
| 700 | 1 | _aShahi, Alisina | |
| 700 | 1 | _aParvizi, Javad | |
| 773 | 0 |
_tThe Journal of arthroplasty _gvol. 33 _gno. 4 _gp. 1258-1264 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.arth.2017.11.031 _zAvailable from publisher's website |
| 999 |
_c27971925 _d27971925 |
||